ROKIT Healthcare Subsidiary ROKIT AMERICA Pursues Nasdaq Listing: $25M Public Offering
- ROKIT Healthcare subsidiary ROKIT AMERICA, Inc. filed an amended Form S-1 to pursue listing on Nasdaq Global Market
- Offering size: 2,631,579 new shares at expected price of $9.50 per share, raising $25 million
- Over-allotment option (45 days) allows up to 394,737 additional shares, total up to $28.75 million
- Underwriter Maxim Group LLC will purchase all offered shares on a firm commitment basis
- Expected post-offering market cap approx. $262.5 million (KRW 380 billion) based on 27,631,679 total shares
- Purpose: expand long-term regeneration platform (ORP) and reverse-aging business in Americas, secure independent funding
- ROKIT Healthcare holds 100% of pre-offering shares; dilution expected post-listing
- Shares issued via electronic registration; restricted from acquisition by Korean residents for a period
- Final listing subject to SEC and Nasdaq approval, final offering price determination; listing date not yet set
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: [Correction of Description] Decision on Listing of Overseas Securities Market Stocks etc. (Major Management Matters of Subsidiary)
- Company: ROKIT HEALTHCARE (376900)
- Submission: ROKIT HEALTHCARE Inc.
- Receipt: 05-11-2026
- Under KRX KOSDAQ Market Division